108 related articles for article (PubMed ID: 10930091)
1. Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells.
Vasaturo F; Dougherty GW; Cutler ML
Breast Cancer Res Treat; 2000 May; 61(1):69-78. PubMed ID: 10930091
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation.
Masuelli L; Cutler ML
Mol Cell Biol; 1996 Oct; 16(10):5466-76. PubMed ID: 8816460
[TBL] [Abstract][Full Text] [Related]
3. The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression.
Masuelli L; Ettenberg S; Vasaturo F; Vestergaard-Sykes K; Cutler ML
Cell Growth Differ; 1999 Aug; 10(8):555-64. PubMed ID: 10470855
[TBL] [Abstract][Full Text] [Related]
4. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells.
Dougherty GW; Jose C; Gimona M; Cutler ML
Eur J Cell Biol; 2008 Sep; 87(8-9):721-34. PubMed ID: 18436335
[TBL] [Abstract][Full Text] [Related]
5. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions.
Dougherty GW; Chopp T; Qi SM; Cutler ML
Exp Cell Res; 2005 May; 306(1):168-79. PubMed ID: 15878342
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).
Gkretsi V; Louca M; Stylianou A; Minadakis G; Spyrou GM; Stylianopoulos T
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621163
[TBL] [Abstract][Full Text] [Related]
7. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
8. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells.
Lynch L; Vodyanik PI; Boettiger D; Guvakova MA
Mol Biol Cell; 2005 Jan; 16(1):51-63. PubMed ID: 15509657
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors.
Hines SJ; Litz JS; Krystal GW
Breast Cancer Res Treat; 1999 Nov; 58(1):1-10. PubMed ID: 10634512
[TBL] [Abstract][Full Text] [Related]
11. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
13. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction in fibroblasts stably transformed by [Val12]Ras--the activities of extracellular-signal-regulated kinase and Jun N-terminal kinase are only moderately increased, and the activity of the delta-inhibitor of c-Jun is not alleviated.
Ljungdahl S; Linder S; Sollerbrant K; Svensson C; Shoshan MC
Eur J Biochem; 1997 Nov; 249(3):648-56. PubMed ID: 9395309
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells.
Radisavljevic Z
Cancer; 2003 Mar; 97(5):1358-63. PubMed ID: 12599246
[TBL] [Abstract][Full Text] [Related]
17. The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential.
Tsuda T; Marinetti MR; Masuelli L; Cutler ML
Oncogene; 1995 Jul; 11(2):397-403. PubMed ID: 7624154
[TBL] [Abstract][Full Text] [Related]
18. Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas.
Chunduru S; Kawami H; Gullick R; Monacci WJ; Dougherty G; Cutler ML
J Neurooncol; 2002 Dec; 60(3):201-11. PubMed ID: 12510772
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
20. Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells.
Fitzgerald KA; Bowie AG; Skeffington BS; O'Neill LA
J Immunol; 2000 Feb; 164(4):2053-63. PubMed ID: 10657658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
